Back
ESC Professional Premium Access

Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction

Session: Covid-19 and heart failure
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mrs K. Gryglewska-Wawrzak (Lodz, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Mrs Katarzyna Gryglewska-Wawrzak

Polish Mother Memorial Hospital Research Institute, Lodz (Poland)
3 presentations
0 follower

7 more presentations in this session

Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study

Speaker: Ms C. Clausen (Hellerup, DK)

Access
Abstract
Slides
Like
Thumbnail

Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial

Speaker: Professor M. Kleiner Shochat (Hadera, IL)

Access
Abstract
Slides
Like
Thumbnail

The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19

Speaker: Doctor R. Bruno (Duesseldorf, DE)

Access
Abstract
Slides
Like
Thumbnail

History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden.

Speaker: Doctor V. Ritsinger (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

Speaker: Doctor M. Bergami (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Covid-19 and heart failure

Speakers: Mrs K. Gryglewska-Wawrzak, Ms C. Clausen, Professor M. Kleiner Shochat, Doctor R. Bruno, Doctor V. Ritsinger...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources